Badalzadeh Mohsen, Mazinani Marzieh, Pourpak Zahra, Heidarnazhad Hassan, Mortaz Esmaeil, Moin Mostafa, Farazmand Ali
Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Allergy Asthma Immunol. 2019 Aug 17;18(4):358-368. doi: 10.18502/ijaai.v18i4.1414.
In this study, we first tried to determine whether the expression level of 9 miRNAs in the peripheral blood CD8+ T cells of asthmatic patients varies from that of controls, and secondly, we investigated the effects of fluticasone furoate and vilanterol on the expression level of these miRNAs. Fifteen subjects including 8 healthy individuals and 7 asthmatic patients were included in this study. CD8+T cells were isolated from participants' peripheral blood by a negative selection method using magnetic-activated cell sorting (MACS). The expression of 9 miRNAs was examined between the healthy individuals and asthmatic patients. Then the expression level of 9 miRNAs before and after treatment with the drugs was examined by quantitative real-time PCR. No significant changes in the expression level of 9 miRNAs were observed in asthmatic patients compared to the healthy controls. Fluticasone and vilanterol, in combination, had the greatest effect on miRNA expression. MiR-150 and miR-106a were the most and the least miRNAs, respectively, present in CD8+ T cells of patients and controls. MiR-106a and miR-126 had a positive correlation in CD8+ cells of asthmatic patients. Although no significant difference in the expression level of studies miRNAs was observed, the correlations among miRNAs were significant. Therefore, we suggest that the correlation between miRNAs would be a very important factor in physiological and pathological conditions in healthy individuals and asthmatic patients. Such a miRNA-miRNA correlation network can be even more critical than any changes in the variation of their expression in the CD8+ T cells.
在本研究中,我们首先试图确定哮喘患者外周血CD8+ T细胞中9种微小RNA(miRNA)的表达水平与对照组是否存在差异,其次,我们研究了糠酸氟替卡松和维兰特罗对这些miRNA表达水平的影响。本研究纳入了15名受试者,包括8名健康个体和7名哮喘患者。采用磁珠法通过阴性选择从参与者外周血中分离CD8+ T细胞。检测了健康个体和哮喘患者之间9种miRNA的表达。然后通过定量实时聚合酶链反应检测用药前后9种miRNA的表达水平。与健康对照组相比,哮喘患者中9种miRNA的表达水平未观察到显著变化。氟替卡松和维兰特罗联合使用对miRNA表达的影响最大。miR-150和miR-106a分别是患者和对照组CD8+ T细胞中含量最多和最少的miRNA。在哮喘患者的CD8+细胞中,miR-106a和miR-126呈正相关。尽管研究的miRNA表达水平未观察到显著差异,但miRNA之间的相关性显著。因此,我们认为miRNA之间的相关性在健康个体和哮喘患者的生理和病理状况中是一个非常重要的因素。这样一个miRNA-miRNA相关网络甚至可能比它们在CD8+ T细胞中表达变化的任何改变都更为关键。